Negative Trade-Off between Neoantigen Repertoire Breadth and the Specificity of HLA-I Molecules Shapes Antitumor Immunity

Scientists quantified peptide repertoire breadth of a representative set of HLA-I alleles and found that patients with cancer who were carrying HLA-I alleles with high peptide-binding promiscuity have significantly worse prognosis after immune checkpoint inhibition.